Analyze Diet

Ortholog-specific Spatial Expression of Vanins in the Respiratory Tract of Horses.

Abstract: Equine asthma (EA) is the most prevalent chronic respiratory disease in horses, but molecules thought to be relevant in its pathogenesis are not yet fully understood. Recently, increased Vanin-1 (VNN1) levels were found in bronchoalveolar lavage fluid from horses with severe EA. Human VNN1 is known as a pantetheinase, which is associated with respiratory diseases such as asthma, but the equine vanins (eVNNs) are uncharacterized. We identified the domain architecture of eVNN in silico and analyzed its tissue expression in healthy horses using RT-PCR (=5) and in situ hybridization (=3). Recombinant eVNNs were expressed in HEK293 cells to assess cellular transport and glycosylation via Endo H and PNGase F treatment. Three putative functional were identified on chromosome 10, each containing canonical Nitrilase superfamily domains. All genes showed a broad tissue expression, but distinct airway localization: and were predominantly expressed in respiratory epithelium, whereas was localized in submucosal glands. eVNN1 and eVNN3 were secreted, while eVNN2 remained cell associated. Pantetheinase activity of recombinant eVNN1 was confirmed by mass spectrometry. The three eVNNs appear to cover different functional niches in equine airways, enabling future research into their putative role in EA.
Publication Date: 2026-08-31 PubMed ID: 42670687PubMed Central: PMC13530036DOI: 10.1369/00221554261474565Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Plain Language Overview

  • This research investigates the expression and characteristics of vanin proteins in the respiratory tract of healthy horses, focusing on their potential role in equine asthma, a common chronic lung disease in horses.

Introduction and Background

  • Equine asthma (EA) is the most widespread chronic respiratory condition affecting horses, yet the molecular mechanisms driving its development are not fully understood.
  • Vanin-1 (VNN1), a pantetheinase enzyme, has been associated with human respiratory diseases such as asthma and was found at elevated levels in the lung fluid of horses suffering from severe EA.
  • Despite its significance in humans, the equine counterparts of vanins (eVNNs) have not been characterized prior to this study.

Objective and Methods

  • The study aimed to characterize the domain structure and spatial expression of equine vanins (eVNNs) and to understand their biochemical properties.
  • In silico analyses were conducted to identify the domain architecture of the eVNN proteins.
  • Tissue expression of the identified eVNN genes was examined in healthy horses using:
    • Reverse transcription polymerase chain reaction (RT-PCR) on samples from five horses.
    • In situ hybridization on samples from three horses to localize the expression within airway tissues.
  • Recombinant forms of eVNN proteins were produced in HEK293 cells to analyze:
    • Cellular transport mechanisms.
    • Protein glycosylation status using Endoglycosidase H (Endo H) and Peptide-N-Glycosidase F (PNGase F) treatments.
  • Pantetheinase enzyme activity was validated for recombinant eVNN1 using mass spectrometry.

Key Findings

  • Three putative functional vanin genes were identified on equine chromosome 10.
  • Each gene contained canonical domains characteristic of the Nitrilase superfamily, indicating conserved enzymatic capabilities.
  • Tissue expression analysis revealed:
    • All three genes exhibited broad expression across multiple tissues.
    • Distinct localization patterns within airway tissue:
      • eVNN1 and eVNN3 were primarily expressed in the respiratory epithelium.
      • eVNN2 expression was predominant in the submucosal glands of the airway.
  • Protein characterization showed:
    • Both eVNN1 and eVNN3 proteins were secreted from cells, suggesting roles in extracellular processes.
    • eVNN2 remained associated with the cell, implying a potentially different functional role.
    • Successful confirmation of pantetheinase activity for recombinant eVNN1 enzyme.

Significance and Future Directions

  • The three eVNN proteins likely fulfill distinct functional roles in the equine respiratory system based on their spatial expression and secretion profiles.
  • Understanding these differences enhances the foundation for investigating their involvement in the development or progression of equine asthma.
  • This work opens pathways for future research focusing on the specific contributions of each eVNN to airway health and disease, potentially leading to novel therapeutic targets or biomarkers for equine asthma.

Cite This Article

APA
Landmann K, Bartenschlager F, Meierhofer D, Spree A, Pisch C, Zeyner A, Schnabel CL, Mundhenk L. (2026). Ortholog-specific Spatial Expression of Vanins in the Respiratory Tract of Horses. J Histochem Cytochem, 221554261474565. https://doi.org/10.1369/00221554261474565

Publication

ISSN: 1551-5044
NlmUniqueID: 9815334
Country: United States
Language: English
Pages: 221554261474565
PII: 00221554261474565

Researcher Affiliations

Landmann, Katharina
  • Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Bartenschlager, Florian
  • Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Meierhofer, David
  • Max Planck Institute for Molecular Genetics, Berlin, Germany.
Spree, Andreas
  • Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Pisch, Caroline
  • Institute of Agricultural and Nutritional Sciences, Martin Luther University Halle-Wittenberg, Halle, Germany.
Zeyner, Annette
  • Institute of Agricultural and Nutritional Sciences, Martin Luther University Halle-Wittenberg, Halle, Germany.
Schnabel, Christiane L
  • Institute of Immunology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.
Mundhenk, Lars
  • Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.

Conflict of Interest Statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

This article includes 62 references
  1. Mims JW. Asthma: definitions and pathophysiology.. Int Forum Allergy Rhinol 2015;5(Suppl. 1):S2–6.
    doi: 10.1002/alr.21609pubmed: 26335832google scholar: lookup
  2. Couetil L, Cardwell JM, Leguillette R, Mazan M, Richard E, Bienzle D, Bullone M, Gerber V, Ivester K, Lavoie JP, Martin J, Moran G, Niedźwiedź A, Pusterla N, Swiderski C. Equine asthma: current understanding and future directions.. Front Vet Sci 2020;7:450.
    doi: 10.3389/fvets.2020.00450pmc: PMC7438831pubmed: 32903600google scholar: lookup
  3. Wasko AJ, Barkema HW, Nicol J, Fernandez N, Logie N, Léguillette R. Evaluation of a risk-screening questionnaire to detect equine lung inflammation: results of a large field study.. Equine Vet J 2011;43(2):145–52.
  4. Davis KU, Sheats MK. Bronchoalveolar lavage cytology characteristics and seasonal changes in a herd of pastured teaching horses.. Front Vet Sci 2019;6:74.
    doi: 10.3389/fvets.2019.00074pmc: PMC6426765pubmed: 30923711google scholar: lookup
  5. Woodrow JS, Sheats MK, Cooper B, Bayless R. Asthma: the use of animal models and their translational utility.. Cells 2023;12(7):1091.
    doi: 10.3390/cells12071091pmc: PMC10093022pubmed: 37048164google scholar: lookup
  6. Couëtil LL, Cardwell JM, Gerber V, Lavoie JP, Léguillette R, Richard EA. Inflammatory airway disease of horses–revised consensus statement.. J Vet Intern Med 2016;30(2):503–15.
    doi: 10.1111/jvim.13824pmc: PMC4913592pubmed: 26806374google scholar: lookup
  7. Bond S, Léguillette R, Richard EA, Couetil L, Lavoie JP, Martin JG, Pirie RS. Equine asthma: integrative biologic relevance of a recently proposed nomenclature.. J Vet Intern Med 2018;32(6):2088–98.
    doi: 10.1111/jvim.15302pmc: PMC6271326pubmed: 30294851google scholar: lookup
  8. Bartenschlager F, Kuropka B, Schmitz P, Dumke F, Landmann K, Gruber AD, Weise C, Schnabel CL, Gehlen H, Mundhenk L. Proteomic profiling of equine airway mucus reveals compositional changes in asthmatic phenotypes.. Sci Rep 2026;16(1):5880.
    doi: 10.1038/s41598-026-38766-3pmc: PMC12894910pubmed: 41667845google scholar: lookup
  9. Kaskow BJ, Proffitt JM, Blangero J, Moses EK, Abraham LJ. Diverse biological activities of the vascular non-inflammatory molecules–the Vanin pantetheinases.. Biochem Biophys Res Commun 2012;417(2):653–8.
    doi: 10.1016/j.bbrc.2011.11.099pmc: PMC3259148pubmed: 22155241google scholar: lookup
  10. Xing Y, Wei H, Xiao X, Chen Z, Liu H, Tong X, Zhou W. Methylated Vnn1 at promoter regions induces asthma occurrence via the PI3K/Akt/NFkappaB-mediated inflammation in IUGR mice.. Biol Open 2020;9(4):bio049106.
    doi: 10.1242/bio.049106pmc: PMC7197710pubmed: 32139393google scholar: lookup
  11. Bartucci R, Salvati A, Olinga P, Boersma YL. Vanin 1: its physiological function and role in diseases.. Int J Mol Sci 2019;20(16):3891.
    doi: 10.3390/ijms20163891pmc: PMC6719204pubmed: 31404995google scholar: lookup
  12. Jansen PA, Kamsteeg M, Rodijk-Olthuis D, van Vlijmen-Willems IM, de Jongh GJ, Bergers M, Tjabringa GS, Zeeuwen PL, Schalkwijk J. Expression of the Vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines.. J Invest Dermatol 2009;129(9):2167–74.
    doi: 10.1038/jid.2009.67pubmed: 19322213google scholar: lookup
  13. Berruyer C, Martin FM, Castellano R, Macone A, Malergue F, Garrido-Urbani S, Millet V, Imbert J, Duprè S, Pitari G, Naquet P, Galland F. Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress.. Mol Cell Biol 2004;24(16):7214–24.
  14. Besouw M, Masereeuw R, van den Heuvel L, Levtchenko E. Cysteamine: an old drug with new potential.. Drug Discov Today 2013;18(15–16):785–92.
    doi: 10.1016/j.drudis.2013.02.003pubmed: 23416144google scholar: lookup
  15. Jeitner TM, Lawrence DA. Mechanisms for the cytotoxicity of cysteamine.. Toxicol Sci 2001;63(1):57–64.
    doi: 10.1093/toxsci/63.1.57pubmed: 11509744google scholar: lookup
  16. Pitari G, Malergue F, Martin F, Philippe JM, Massucci MT, Chabret C, Maras B, Dupre S, Naquet P, Galland F. Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice.. FEBS Lett 2000;483(2–3):149–54.
    doi: 10.1016/s0014-5793(00)02110-4pubmed: 11042271google scholar: lookup
  17. Lebo RV, Kredich NM. Inactivation of human gamma-glutamylcysteine synthetase by cystamine. Demonstration and quantification of enzyme-ligand complexes.. J Biol Chem 1978;253(8):2615–3.
    doi: 10.1016/S0021-9258(17)40865-9pubmed: 24639google scholar: lookup
  18. Bolcas PE, Brandt EB, Ruff BP, Kalra M, Khurana Hershey GK. Cysteamine prevents asthma development and reduces airway hyperresponsiveness in experimental asthma.. Allergy 2020;75(10):2675–7.
    doi: 10.1111/all.14332pubmed: 32311100google scholar: lookup
  19. Xiao C, Biagini Myers JM, Ji H, Metz K, Martin LJ, Lindsey M, He H, Powers R, Ulm A, Ruff B, Ericksen MB, Somineni HK, Simmons J, Strait RT, Kercsmar CM, Khurana Hershey GK. Vanin-1 expression and methylation discriminate pediatric asthma corticosteroid treatment response.. J Allergy Clin Immunol 2015;136(4):923–31.
    doi: 10.1016/j.jaci.2015.01.045pmc: PMC4586304pubmed: 25910714google scholar: lookup
  20. Martin F, Malergue F, Pitari G, Philippe JM, Philips S, Chabret C, Granjeaud S, Mattei MG, Mungall AJ, Naquet P, Galland F. Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode isoforms of pantetheinase ectoenzymes.. Immunogenetics 2001;53(4):296–306.
    doi: 10.1007/s002510100327pubmed: 11491533google scholar: lookup
  21. Granjeaud S, Naquet P, Galland F. An ESTs description of the new Vanin gene family conserved from fly to human.. Immunogenetics 1999;49(11–12):964–72.
    doi: 10.1007/s002510050580pubmed: 10501839google scholar: lookup
  22. Galland F, Malergue F, Bazin H, Mattei MG, Aurrand-Lions M, Theillet C, Naquet P. Two human genes related to murine Vanin-1 are located on the long arm of human chromosome 6.. Genomics 1998;53(2):203–13.
    doi: 10.1006/geno.1998.5481pubmed: 9790769google scholar: lookup
  23. Aurrand-Lions M, Galland F, Bazin H, Zakharyev VM, Imhof BA, Naquet P. Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing.. Immunity 1996;5(5):391–405.
    doi: 10.1016/s1074-7613(00)80496-3pubmed: 8934567google scholar: lookup
  24. Sayers EW, Beck J, Bolton EE, Brister JR, Chan J, Connor R, Feldgarden M, Fine AM, Funk K, Hoffman J, Kannan S, Kelly C, Klimke W, Kim S, Lathrop S, Marchler-Bauer A, Murphy TD, O’Sullivan C, Schmieder E, Skripchenko Y, Stine A, Thibaud-Nissen F, Wang J, Ye J, Zellers E, Schneider VA, Pruitt KD. Database resources of the National Center for Biotechnology Information in 2025.. Nucleic Acids Res 2025;53(D1):D20–9.
    doi: 10.1093/nar/gkae979pmc: PMC11701734pubmed: 39526373google scholar: lookup
  25. Dyer SC, Austine-Orimoloye O, Azov AG, Barba M, Barnes I, Barrera-Enriquez VP, Becker A, Bennett R, Beracochea M, Berry A, Bhai J, Bhurji SK, Boddu S, Branco Lins PR, Brooks L, Ramaraju SB, Campbell LI, Martinez MC, Charkhchi M, Cortes LA, Davidson C, Denni S, Dodiya K, Donaldson S, El Houdaigui B, El Naboulsi T, Falola O, Fatima R, Genez T, Martinez JG, Gurbich T, Hardy M, Hollis Z, Hunt T, Kay M, Kaykala V, Lemos D, Lodha D, Mathlouthi N, Merino GA, Merritt R, Mirabueno LP, Mushtaq A, Hossain SN, Pérez-Silva JG, Perry M, Piližota I, Poppleton D, Prosovetskaia I, Raj S, Salam AIA, Saraf S, Saraiva-Agostinho N, Sinha S, Sipos B, Sitnik V, Steed E, Suner M-M, Surapaneni L, Sutinen K, Tricomi FF, Tsang I, Urbina-Gómez D, Veidenberg A, Walsh TA, Willhoft NL, Allen J, Alvarez-Jarreta J, Chakiachvili M, Cheema J, Da Rocha JB, Silva NH, de Giorgetti S, Haggerty L, Ilsley GR, Keatley J, Loveland JE, Moore B, Mudge JM, Naamati G, Tate J, Trevanion SJ, Winterbottom A, Flint B, Frankish A, Hunt SE, Finn RD, Freeberg MA, Harrison PW, Martin FJ, Yates AD. Ensembl 2025.. Nucleic Acids Res 2025;53(D1):D948–57.
    doi: 10.1093/nar/gkae1071pmc: PMC11701638pubmed: 39656687google scholar: lookup
  26. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool.. J Mol Biol 1990;215(3):403–10.
    doi: 10.1016/S0022-2836(05)80360-2spubmed: 2231712google scholar: lookup
  27. Madeira F, Madhusoodanan N, Lee J, Eusebi A, Niewielska A, Tivey ARN, Lopez R, Butcher S. The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024.. Nucleic Acids Res 2024;52(W1):W521–5.
    doi: 10.1093/nar/gkae241pmc: PMC11223882pubmed: 38597606google scholar: lookup
  28. Hirokawa T, Boon-Chieng S, Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins.. Bioinformatics 1998;14(4):378–9.
  29. Pierleoni A, Martelli PL, Casadio R. PredGPI: a GPI-anchor predictor.. BMC Bioinformatics 2008;9:392.
    doi: 10.1186/1471-2105-9-392pmc: PMC2571997pubmed: 18811934google scholar: lookup
  30. Gupta R, Brunak S. Prediction of glycosylation across the human proteome and the correlation to protein function.. Pac Symp Biocomput 2002:310–22.
    pubmed: 11928486
  31. Almagro Armenteros JJ, Tsirigos KD, Sønderby CK, Petersen TN, Winther O, Brunak S, Heijne G, von Nielsen H. SignalP 5.0 improves signal peptide predictions using deep neural networks.. Nat Biotechnol 2019;37(4):420–3.
    doi: 10.1038/s41587-019-0036-zpubmed: 30778233google scholar: lookup
  32. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput.. Nucleic Acids Res 2004;32(5):1792–7.
    doi: 10.1093/nar/gkh340pmc: PMC390337pubmed: 15034147google scholar: lookup
  33. Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11.. Mol Biol Evol 2021;38(7):3022–7.
    doi: 10.1093/molbev/msab120pmc: PMC8233496pubmed: 33892491google scholar: lookup
  34. Anton F, Leverkoehne I, Mundhenk L, Thoreson WB, Gruber AD. Overexpression of eCLCA1 in small airways of horses with recurrent airway obstruction.. J Histochem Cytochem 2005;53(8):1011–21.
    doi: 10.1369/jhc.4A6599.2005pmc: PMC1383431pubmed: 15879574google scholar: lookup
  35. Ruan BH, Cole DC, Wu P, Quazi A, Page K, Wright JF, Huang N, Stock JR, Nocka K, Aulabaugh A, Krykbaev R, Fitz LJ, Wolfman NM, Fleming ML. A fluorescent assay suitable for inhibitor screening and Vanin tissue quantification.. Anal Biochem 2010;399(2):284–92.
    doi: 10.1016/j.ab.2009.12.010pubmed: 20018163google scholar: lookup
  36. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction.. BMC Bioinformatics 2012;13:134.
    doi: 10.1186/1471-2105-13-134pmc: PMC3412702pubmed: 22708584google scholar: lookup
  37. Bartenschlager F, Klymiuk N, Weise C, Kuropka B, Gruber AD, Mundhenk L. Evolutionarily conserved properties of CLCA proteins 1, 3 and 4, as revealed by phylogenetic and biochemical studies in avian homologues.. PLoS ONE 2022;17(4):e0266937.
  38. Schmidbauer S-M, Venner M, Samson-Himmelstjerna G, von Drommer W, Gruber AD. Compensated overexpression of procollagens alpha 1(I) and alpha 1(III) following perilla mint ketone-induced acute pulmonary damage in horses.. J Comp Pathol 2004;131(2–3):186–98.
    doi: 10.1016/j.jcpa.2004.03.005pubmed: 15276858google scholar: lookup
  39. Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, Hamilton PW. QuPath: open source software for digital pathology image analysis.. Sci Rep 2017;7(1):16878.
    doi: 10.1038/s41598-017-17204-5pmc: PMC5715110pubmed: 29203879google scholar: lookup
  40. Udenfriend S, Kodukula K. How glycosylphosphatidylinositol-anchored membrane proteins are made.. Annu Rev Biochem 1995;64:563–91.
  41. Atallah C, Charcosset C, Greige-Gerges H. Challenges for cysteamine stabilization, quantification, and biological effects improvement.. J Pharm Anal 2020;10(6):499–516.
    doi: 10.1016/j.jpha.2020.03.007pmc: PMC7775854pubmed: 33425447google scholar: lookup
  42. Zhang X, Cong W, Lu A. Vanin-1 as a novel biomarker for chronic obstructive pulmonary disease.. Heart Lung 2022;56:91–5.
    doi: 10.1016/j.hrtlng.2022.06.022pubmed: 35810677google scholar: lookup
  43. Ling L, Lu HT, Wang HF, Shen MJ, Zhang HB. MicroRNA-203 Acts as a Potent Suppressor in Septic Shock by Alleviating Lung Injury via Inhibition of VNN1.. Kidney Blood Press Res 2019;44(4):565–82.
    doi: 10.1159/000500484pubmed: 31340209google scholar: lookup
  44. Suzuki K, Watanabe T, Sakurai S, Ohtake K, Kinoshita T, Araki A, Fujita T, Takei H, Takeda Y, Sato Y, Yamashita T, Araki Y, Sendo F. A novel glycosylphosphatidyl inositol-anchored protein on human leukocytes: a possible role for regulation of neutrophil adherence and migration.. J Immunol 1999;162(7):4277–84.
    pubmed: 10201959
  45. Huang J, Takeda Y, Watanabe T, Sendo F. A sandwich ELISA for detection of soluble GPI-80, a Glycosylphosphatidyl-Inositol (GPI)-anchored protein on human leukocytes involved in regulation of neutrophil adherence and migration—its release from activated neutrophils and presence in synovial fluid.. Microbiol Immunol 2001;45(6):467–71.
  46. Gensollen T, Bourges C, Rihet P, Rostan A, Millet V, Noguchi T, Bourdon V, Sobol H, Dubuquoy L, Bertin B, Fumery M, Desreumaux P, Colombel JF, Chamaillard M, Hebuterne X, Hofman P, Naquet P, Galland F. Functional polymorphisms in the regulatory regions of the VNN1 gene are associated with susceptibility to inflammatory bowel diseases.. Inflamm Bowel Dis 2013;19(11):2315–5.
    doi: 10.1097/MIB.0b013e3182a32b03pubmed: 23949622google scholar: lookup
  47. Pouyet L, Roisin-Bouffay C, Clément A, Millet V, Garcia S, Chasson L, Issaly N, Rostan A, Hofman P, Naquet P, Galland F. Epithelial Vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.. Inflamm Bowel Dis 2010;16(1):96–104.
    doi: 10.1002/ibd.21031pubmed: 19572375google scholar: lookup
  48. Xu Y, Saegusa C, Schehr A, Grant S, Whitsett JA, Ikegami M. C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.. Am J Physiol Lung Cell Mol Physiol 2009;297(2):L286–98.
    doi: 10.1152/ajplung.00094.2009pmc: PMC2742785pubmed: 19465518google scholar: lookup
  49. Bahabayi A, Alimu X, Wang G, Gao Y, Chen Y, Zhao J, Lian X, Li Q, Xiong Z, Zhang Z, Wang P, Liu C. VNN2-expressing circulating monocytes exhibit unique functional characteristics and are decreased in patients with primary Sjögren’s syndrome.. J Autoimmun 2024;147:103275.
    doi: 10.1016/j.jaut.2024.103275pubmed: 38936146google scholar: lookup
  50. Bornhauser B, Cario G, Rinaldi A, Risch T, Rodriguez Martinez V, Schutte M, Warnatz HJ, Scheidegger N, Mirkowska P, Temperli M, Moller C, Schumich A, Dworzak M, Attarbaschi A, Bruggemann M, Ritgen M, Mejstrikova E, Hofmann A, Buldini B, Scarparo P, Basso G, Maglia O, Gaipa G, Skroblyn TL, Ngo Q, Te Kronnie G, Vendramini E, Panzer-Grumayer R, Barz MJ, Marovca B, Hauri-Hohl M, Niggli F, Eckert C, Schrappe M, Stanulla M, Zimmermann M, Wollscheid B, Yaspo ML, Bourquin JP. The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.. Blood Adv 2020;4(17):4052–64.
  51. Huang S-Y, Chen Y-Y, Huang D, Wu C-D, Lin C-T. Abstract 5356: the role of VNN3 gene in nasopharyngeal carcinoma tumorigenesis.. Cancer Res 2014;74(Suppl. 19):5356.
  52. Plog S, Mundhenk L, Klymiuk N, Gruber AD. Genomic, tissue expression, and protein characterization of pCLCA1, a putative modulator of cystic fibrosis in the pig.. J Histochem Cytochem 2009;57(12):1169–81.
    doi: 10.1369/jhc.2009.954594pmc: PMC2778090pubmed: 19755716google scholar: lookup
  53. Duprè S, Graziani MT, Rosei MA, Fabi A, Del Grosso E. The enzymatic breakdown of pantethine to pantothenic acid and cystamine.. Eur J Biochem 1970;16(3):571–8.
  54. Wittwer CT, Burkhard D, Ririe K, Rasmussen R, Brown J, Wyse BW, Hansen RG. Purification and properties of a pantetheine-hydrolyzing enzyme from pig kidney.. J Biol Chem 1983;258(16):9733–8.
    doi: 10.1016/S0021-9258(17)44559-5pubmed: 6885768google scholar: lookup
  55. Maras B, Barra D, Duprè S, Pitari G. Is pantetheinase the actual identity of mouse and human Vanin-1 proteins?. FEBS Letters 1999;461(3):149–52.
    doi: 10.1016/s0014-5793(99)01439-8pubmed: 10567687google scholar: lookup
  56. Nitto T, Onodera K. Linkage between coenzyme a metabolism and inflammation: roles of pantetheinase.. J Pharmacol Sci 2013;123(1):1–8.
    doi: 10.1254/jphs.13r01cppubmed: 23978960google scholar: lookup
  57. Devereux G, Steele S, Griffiths K, Devlin E, Fraser-Pitt D, Cotton S, Norrie J, Chrystyn H, O’Neil D. An open-label investigation of the pharmacokinetics and tolerability of oral cysteamine in adults with cystic fibrosis.. Clin Drug Investig 2016;36(8):605–12.
    doi: 10.1007/s40261-016-0405-zpmc: PMC4951511pubmed: 27153825google scholar: lookup
  58. Charrier C, Rodger C, Robertson J, Kowalczuk A, Shand N, Fraser-Pitt D, Mercer D, O’Neil D. Cysteamine (Lynovex(R)), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.. Orphanet J Rare Dis 2014;9:189.
    doi: 10.1186/s13023-014-0189-2pmc: PMC4260250pubmed: 25433388google scholar: lookup
  59. Oh K, Seo MW, Lee GY, Byoun OJ, Kang HR, Cho SH, Lee DS. Airway epithelial cells initiate the allergen response through transglutaminase 2 by inducing IL-33 expression and a subsequent Th2 response.. Respir Res 2013;14(1):35.
    doi: 10.1186/1465-9921-14-35pmc: PMC3602182pubmed: 23496815google scholar: lookup
  60. Xie Y, Abel PW, Casale TB, Tu Y. T(H)17 cells and corticosteroid insensitivity in severe asthma.. J Allergy Clin Immunol 2022;149(2):467–79.
    doi: 10.1016/j.jaci.2021.12.769pmc: PMC8821175pubmed: 34953791google scholar: lookup
  61. Simoes J, Batista M, Tilley P. The immune mechanisms of severe equine asthma-current understanding and what is missing.. Animals (Basel) 2022;12(6):744.
    doi: 10.3390/ani12060744pmc: PMC8944511pubmed: 35327141google scholar: lookup
  62. Wang KCW, James AL, Noble PB. Fetal growth restriction and asthma: is the damage done?. Physiology (Bethesda) 2021;36(4):256–66.
    doi: 10.1152/physiol.00042.2020pubmed: 34159809google scholar: lookup

Citations

This article has been cited 0 times.